Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Avalo Therapeutics Inc., 2 years.
Avalo Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Avalo Therapeutics Inc. June 17, 202599.9%
-
Avalo Therapeutics Inc. August 13, 202498.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 28, 2026 | Avalo Therapeutics Inc. | Option exercise | +3,166 | — | — |
| Nov 14, 2025 | Avalo Therapeutics Inc. | Open-market sale | −3,167 | $14.30 | $45,288 |
| Nov 14, 2025 | Avalo Therapeutics Inc. | Option exercise | +8,200 | $9.88 | $81,016 |
| Nov 14, 2025 | Avalo Therapeutics Inc. | Open-market sale | −8,200 | $14.35 | $117,670 |
| Mar 28, 2025 | Avalo Therapeutics Inc. | Option exercise | +3,167 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.